Other cardiovascular syphilis
ICD-10 A52.09 is a billable code used to indicate a diagnosis of other cardiovascular syphilis.
Other cardiovascular syphilis (A52.09) refers to cardiovascular manifestations of syphilis that do not fall under the more specific categories of aortic aneurysm or aortic regurgitation. This condition can arise during the tertiary stage of syphilis, where the infection can lead to significant cardiovascular complications, including endarteritis, aortitis, and coronary artery disease. Patients may present with symptoms such as chest pain, heart failure, or signs of ischemia. Diagnosis typically involves serological testing for Treponema pallidum, the bacterium responsible for syphilis, alongside imaging studies to assess cardiovascular involvement. Treatment primarily consists of antibiotic therapy, usually with penicillin, which is effective in managing the infection and preventing further cardiovascular damage. Regular follow-up and monitoring are essential to assess treatment efficacy and manage any arising complications. Given the potential for severe outcomes, timely diagnosis and intervention are critical in managing this condition.
Detailed patient history, serological test results, and treatment plans.
Patients presenting with atypical symptoms of syphilis, including cardiovascular complaints.
Documentation must clearly outline the relationship between syphilis and cardiovascular symptoms.
Comprehensive cardiovascular assessments, imaging results, and treatment responses.
Patients with known syphilis presenting with chest pain or heart failure.
Cardiologists should document the syphilis history and its impact on cardiovascular health.
When testing for syphilis in patients with cardiovascular symptoms.
Document the reason for testing and results.
Infectious disease specialists should ensure comprehensive testing protocols.
Common symptoms include chest pain, shortness of breath, and signs of heart failure. Patients may also experience fatigue and palpitations.
Diagnosis typically involves serological testing for syphilis and imaging studies to assess cardiovascular involvement.
The primary treatment is antibiotic therapy, usually with penicillin, which is effective in managing the infection and preventing further cardiovascular damage.
